-
Recent Posts
- Dog Therapy for Dementia? (BMC Psychiatry / Psychogeriatrics / Bazian / BMC Public Health)
- In the News: Reproduced Without Interpretation or Comment (The Guardian)
- National Audit of Dementia Care in General Hospitals: Spotlight Audit on Psychotropic Medication (HQIP / RCP)
- Digital Social Care Pathfinders: the Social Care Programme (NHS Digital)
- Digital Technology for Early Detection of Neurodegenerative Disease (BBC News / EDoN)
Archives
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Wearable Devices
Digital Technology for Early Detection of Neurodegenerative Disease (BBC News / EDoN)
Summary The Early Detection of Neurodegenerative Diseases (EDoN) initiative, with backing from Alzheimer’s Research UK, is working to develop wearable devices which will collect data to help detect the early stages of Alzheimer’s Disease and other neurodegenerative diseases. Full Text … Continue reading →
Posted in Alzheimer’s Research UK, BBC News, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Quick Insights, UK, Universal Interest
|
Tagged Accelerating Detection of Disease Programme, Alan Turing Institute, Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Research UK (ARUK), Artificial Intelligence (AI), ARUK: Alzheimer’s Research UK, Asymptomatic Alzheimer’s Disease, Automatic Speech Analysis, BBC Health News, BBC Technology News, Behavioural Biomarkers, Benefits of Early Detection, Big Data, Bill and Melinda Gates Foundation, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, CrawfordWorks, David Cameron, David Cameron: Former Prime Minister, Digital Biomarkers, Digital Diagnostic Tools, Digital Fingerprints, Digital Technology, Digital Technology and Innovation, Early Detection of Alzheimer’s Disease, Early Detection of Disease, Early Detection of Neurodegenerative Diseases, Early Detection of Neurodegenerative Diseases (EDoN), Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Dementia, Early Recognition of Alzheimer’s Disease Using Digital Technology, Early Recognition of Neurodegenerative Diseases Using Digital Technology, EDoN Clinical Support Group, EDoN Cohorts and Biomarkers Working Group, EDoN Digital Platform Working Group, EDoN Digital Support Group, EDoN Digital Toolkit, EDoN Digital Tools Working Group, EDoN Fingerprint Analytics Working Group, EDoN White Paper, Ethical Considerations, Ethical Sharing of Data Between Organisations, Fingerprint Analytics, Gait: an Integrative Measure of Health, Heart Rate, Iceland Foods Charitable Foundation, Information Technology, International and Independent External Advisory Board, Investment in Information Technology, Machine Learning Models, Medopad, Mild Cognitive Impairment (MCI), Mindstrong Health, MRC Harwell Institute, National Hospital for Neurology and Neurosurgery: University College London, National Physical Laboratory, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Newcastle University, Non-Invasive Biomarkers, Optimising Benefits of Digital Technology, Preclinical Alzheimer's Disease, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Preclinical Dementia and Associated Lifestyle Changes, Preclinical Indicators and Dementia, Preclinical Indicators in Alzheimer's Disease, Preclinical Phase of Dementia, Prodromal Alzheimer's Disease, Prodromal Dementia, Rates of Conversion From Mild Cognitive Impairment to Dementia, Research Informatics, Sleep Patterns, Smart Phone apps, Smart Sensors, Smart Watches, Target Discovery and Preclinical Validation, Tencent, The Rt Hon David Cameron: Chair of EDoN Board, The Rt Hon David Cameron: President of Alzheimer’s Research UK, Timely / Preclinical Neurodegenerative Diseases Diagnosis, Timely Screening / Preclinical Neurodegenerative Disease, University College London, University of Cambridge, University of Exeter, University of Oxford Big Data Institute, Walking Speed: a Behavioural Biomarker for Neurocognitive and Physical Decline, Wearable Devices, Wearable Monitoring Equipment, Wearable Sensors, Wearable Technology, Wearables (Technology)
|
Leave a comment
Digital Support for People At Risk of Type 2 Diabetes (NHS England / Diabetes Care)
Summary Online support and wearable monitoring technology will be provided for eligible people at risk of developing Type 2 Diabetes, as part of planned extensions to the NHS Diabetes Prevention Programme. This complies with ambitions in the NHS NHS Long … Continue reading →
Posted in Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, National, NHS, NHS England, Person-Centred Care, Personalisation, Public Health England, Quick Insights, Scotland, Standards, Statistics, UK, Universal Interest
|
Tagged Alzheimer Scotland Dementia Research Centre and Centre for Cognitive Ageing and Cognitive Epidemiology: University of Edinburgh, Biomarkers in Medical Records, Bioresources Linked to Electronic Medical Records, Community and Peer Support Programmes for People to Manage Their Care (Involvement Enablers), Dementia and Diabetes, Department of Applied Social Science: University of Stirling, Department of Neuroscience: University of Dundee, Diabetes, Diabetes Care, Diabetes Education, Diabetes Prevention Programme, Diabetes Prevention Services, Digital DPP, Digital Technology, Division of Population Health and Genomics: University of Dundee, Dr Jennifer Smith: Diabetes Programme Director at Public Health England, Electronic Medical Records, GoDARTS Bioresource, Health Informatics Centre: University of Dundee, Joined-Up Healthcare: Digital Technology, Neurological Disorders, NHS Diabetes Prevention Programme (NHS DPP), NHS Diabetes Prevention Programme’s Digital Offerings, NHS Tayside, Nikki Joule: Policy Manager at Diabetes UK, Ninewells Hospital and Medical School (Dundee), Online Peer Support, Optimising Benefits of Digital Technology, Peer Support, Peer Support Networks, Peer Support Services, Preventing Type 2 Diabetes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Better Than Cure, Professor Jonathan Valabhji: National Clinical Director for Diabetes and Obesity at NHS England, School of Science and Engineering: University of Dundee, Scotland, Type 2 Diabetes, Type 2 Diabetes and Alzheimer's Disease, Type 2 Diabetes and Dementia, Type 2 Diabetes and Vascular Dementia Risk, Type 2 Diabetes Mellitus (T2DM), University of Dundee, University of Edinburgh, University of Stirling, VaD: Vascular Dementia, VAMPIRE Project: University of Dundee, Vascular Dementia, Vascular Dementia: Prevention, Wearable Devices, Wearable Monitoring Equipment, Wearable Sensors, Wearable Technology, Wearables (Technology)
|
Leave a comment
More on the Uses of New Technologies in Health and Care (CQC)
Summary The Care Quality Commission (CQC) has created a collection of case studies which explore innovative uses of new technologies in the provision, monitoring and quality improvement of various health and care services. “We are determined that regulation does not stand … Continue reading →
Posted in Acute Hospitals, Assistive Technology, Commissioning, Community Care, CQC: Care Quality Commission, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, UK, Universal Interest
|
Tagged Ageing and Long-Term Care, Ageing Population, AliveCor, AliveCor’s Kardia in Care City Test Bed, Apps, apps for Smartphones or Tablets, Apps Related to Dementia, Assistive Technology (AT), Assistive Technology and Telecare, Assistive Technology Services, Assistive Technology Supporting Independence of People With Dementia, AT: Assistive Technology, Automated Triage Technology, Barriers to Integration: Difficulties in Effective Information Sharing, Barts Health NHS Trust, Benefits of Technology in Care, Broadmoor Hospital, Cambridge University Hospital NHS Foundation Trust, Canterbury and Coastal Clinical Commissioning Group, Care City: Formerly part of North East London NHS Foundation Trust (NELFT), Care Quality Commission (CQC), Central and North West London NHS Foundation Trust, Centre for Vision Speech and Signal Processing: University of Surrey, Communication and Information Sharing, Coordinate My Care (CMC), Coventry and Warwickshire Partnership NHS Trust, Data Security and Information Governance, Data Sharing, Detecting Atrial Fibrillation, Digital Care Assistant (DCA), Digital Innovation, Digital Innovations in Care, Digital Records, Digital Service Transformation, Digital Services, Digital Technology, Digital Technology and Innovation, Digitally-Enabled Care, Dr Malte Gerhold: Director of Strategy and Intelligence at Care Quality Commission (CQC), Driving Improvement Through Technology (CQC), Driving improvement: Case Studies Series (CQC), Electronic Patient Record (EPR), HaMpton app, Headscape Focus: Oxleas NHS Foundation Trust, Healthcare Information and Management Systems Society (HIMSS), Healthlocker: South London and Maudsley NHS Foundation Trust, Healthy.io, HIMSS-Elsevier Outstanding ICT Innovation, Home Monitoring of Hypertension in Pregnancy, Home Monitoring: Patients With Inflammatory Bowel Disease, Improving Care Through Technology, Information Sharing, Information Sharing and Digital Care Records, Information Technology, Informed Consent, Innovative Use of Technology to Help Answer CQC's Five Key Questions, Institute of Biomedical Engineering: Oxford University, InteractiveMe, Internet of Things (IoT), Internet of Things (IoT) Technology in Health and Social Care, Joined-Up Healthcare: Digital Technology, Kings College Hospital NHS Trust, Laptops in Clients' Homes, Leonard Cheshire, mHealth, mHealth (Mobile Health), Modality, Modality Partnership, Monitoring for People With COPD Heart Failure or Type 2 Diabetes, My IBD Care, myCMC, MySense, New Technology, NHS England Test Beds, NHS England Test Beds Programme, NHS Innovation Accelerator (NIA), Online Profiles to Promote Interaction, Online Profiles: InteractiveMe, Optimising Benefits of Digital Technology, Oxehealth, Oxford University Hospitals NHS Foundation Trust, Oxford University: Institute of Biomedical Engineering, Oxleas NHS Foundation Trust, People With Dementia Living at Home, Personal Data, Personal Information, Personal Information to Support Better Care, Personalised Technology, Personalised Technology for Building Social Contact, Real-Time Urgent and Emergency Care Waiting Times, Remote Monitoring Health of People With Dementia Living at Home, Royal Brompton NHS Trust, Royal Holloway (University of London), Royal Marsden NHS Foundation Trust, Salford Royal NHS Foundation Trust, Sensors in the Home, Shared Care Digital Platform: Headscape Focus, Shared Care Plans Across System, Smartphone and Tablet Apps, Smartphone apps, South West London and St George’s Mental Health NHS Trust, St George’s Hospital in London, Steps Ahead Care and Support, Surrey and Borders Partnership NHS Foundation Trust, Surrey and North East Hampshire, Swindon Borough Council, Technology and Infrastructure Development, Technology in Care: Care Quality Commission Series, Technology Integrated Health Management (TIHM) for Dementia, Technology Integrated Health Management for Dementia, Technology Supporting High-Quality Care, Telecare, Telecare and Dementia, Teledermatology, Telemedicine, Telemonitoring, TeleTracking, Test Beds Programme, TIHM (Technology Integrated Health Management) for Dementia, Tracking Patient Care, Transforming Systems: WaitLess app, Triage Technologies, University of Surrey, Use of Data and Technology to Transform Outcomes for Patients and Citizens, WaitLess app (Transforming Systems), Wearable Devices, Wearable Technology, Wearables (Technology), West Yorkshire and Harrogate Cancer Alliance
|
Leave a comment
Technology and Surveillance in Care Services (CQC)
Summary The Care Quality Commission (CQC) has started a series which covers the use of technology in care. The topics explored, so far, comprise: Introduction: how technology can support high-quality care. Using surveillance in care services. Handling personal information. Consent … Continue reading →
Posted in Assistive Technology, Commissioning, Community Care, CQC: Care Quality Commission, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, National, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Practical Advice, Quick Insights, Telecare, Telehealth, UK, Universal Interest
|
Tagged Ageing and Long-Term Care, Ageing Population, Alternatives to Surveillance, Apps, apps for Smartphones or Tablets, Apps Related to Dementia, Assistive Technology (AT), Assistive Technology and Telecare, Assistive Technology Services, Assistive Technology Supporting Independence of People With Dementia, AT: Assistive Technology, Benefits of Technology in Care, Capacity to Consent, Care Quality Commission (CQC), CCTV Monitors, Code of Practice on Confidential Information, Codes of Practice for Handling Information in Health and Care, Confidentiality: NHS Code of Practice, Consent, Consultation Before Using Surveillance, Covert Care Cameras, CQC Inspection Questions (Safe Effective Caring Responsive Well-Led), Customer Safety, Data Protection Impact Assessment (DPIA), Data Security and Information Governance, Data Security and Protection Toolkit (NHS), Data Security Consent and Opt-outs, Department for Business Energy and Industrial Strategy (BEIS): Regulators' Pioneer Fund, Digital Innovation, Digital Innovations in Care, Digital Records, Digital Service Transformation, Digital Services, Digital Technology, Digital Technology and Innovation, Dignity and Consent, Ensuring Correct Personal Information, General Data Protection Regulation (GDPR), Hidden Cameras, Hidden or Visible Cameras to Monitor Care Quality, Hidden Surveillance to Monitor Care, HSCIC Guide to Confidentiality (2013), Human Rights Act (UK Parliament 1998), Human Rights Act 1998: Article 8 on Right to Privacy, ICO's CCTV Code of Practice, Information and Support for Providers and Carers, Information Commissioner’s Office (ICO), Information Governance, Information Security Management: NHS Code of Practice, Information Technology, Informed Consent, Innovative Use of Technology to Help Answer CQC's Five Key Questions, Legal Advice Before Use of Technology to Monitor Without Explicit Consent, mHealth (Mobile Health), mHealth Apps, National Data Guardian's Ten Data Security Standards, Needs Assessment, New Technology, NHS Digital Data Security and Protection Toolkit, NHS Information Governance: Guidance, Open and Covert Surveillance, Optimising Benefits of Digital Technology, Patient Safety, Personal Data, Personal Information, Personal Information to Support Better Care, Personal Information: Guidance, Personalised Technology, Personalised Technology for Building Social Contact, Privacy and Choice, Protectiion of Privacy in Surveillance, Recording Equipment: Permission (Consent), Records Management Code of Practice for Health and Social Care 2016, Refusal or Withdrawal of Consent, Regulation of Investigatory Powers Act 2000 (RIPA), Regulators' Pioneer Fund, Regulatory Sandboxing, Right to Privacy, Risk and Consent, Smartphone and Tablet Apps, Smartphone apps, Special Category Data, Surveillance, Surveillance Camera Code of Practice, Surveillance Equipment, Surveillance to Monitor Care, Surveillance Training, Technology and Infrastructure Development, Technology in Care: Care Quality Commission Series, Technology Supporting High-Quality Care, Telemedicine, TeleTracking, Text Messaging, Tracking Patient Care, Use of Data and Technology to Transform Outcomes for Patients and Citizens, Wearable Devices, Wearable Technology, Wearables (Technology)
|
Leave a comment
Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)
Summary The Deep and Frequent Phenotyping Study aims to discover new ways of diagnosing dementia, ideally decades before the symptoms become apparent in order to give future drug treatments the best chance of working. The Deep and Frequent Phenotyping Study … Continue reading →
Posted in Alzheimer's Society, BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, NIHR, Quick Insights, UK, Universal Interest
|
Tagged Ageing Population, Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Applications of Big Data, BBC Radio, BBC Radio 4, BBC's World At One Programme, Big Data Analytics, Big Data Funding and Research, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Neuropsychological Test Automated Battery (CANTAB), Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Deep and Frequent Phenotyping Study (DFP), Deep and Frequent Phenotyping; Combinatorial Biomarkers of Dementia, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, DFP Study Team, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Gait and Cognition, Gait Changes, Gateway to Research (GtR), Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, Join Dementia Research, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurobiology of Aging (Journal), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Open Data and Big Data, Ophthalmological Assessments, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, PharmaCog Consortium, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Clare Mackay: Imaging Neuroscience at the University of Oxford, Professor Lynn Rochester: Clinical Ageing Research Unit at Newcastle University, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Publicly-Funded UK Big Data Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), Surrogate Biomarkers of Neurodegeneration, Translational Research, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology)
|
Leave a comment
The Dementia Citizens Project (Knowledge Hub / Nesta)
Summary The National Endowment for Science Technology and the Arts (Nesta) has launched the Dementia Citizens website. This project aims to bring together researchers and people with dementia (and their carers and families) with a view to discovering novel ways … Continue reading →
Posted in Acute Hospitals, Alzheimer's Society, Alzheimer’s Research UK, Assistive Technology, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Patient Information, Person-Centred Care, Personalisation, Practical Advice, Quick Insights, Scotland, Telecare, Telehealth, UK, Universal Interest, Wales
|
Tagged Active Citizens, Arts and Music in Dementia, Arts in Health, Assistive Technology (AT), Assistive Technology and Telecare, Assistive Technology Services, Assistive Technology Supporting Independence of People With Dementia, AT: Assistive Technology, Bangor University, Book of You (Nesta backed by Bangor University), Citizen Inclusion, Citizen Participation, Citizenship: Involvement and Participation, Cognitive Stimulation, Cognitive Stimulation Therapy (CST), Ctrl Group: Nesta Development Partners, Cultural Arts Interventions, Dementia and Social Citizenship, Dementia Research, Dementia Services Development Centre, Dementia Services Development Centre (DSDC Wales): Bangor University, Dementia Services Development Centre Wales: Bangor University, Dementia-Friendly apps, Dementia-Related apps, Digital Arts and Older People, Digital Reminiscence Therapy, Glasgow Caledonian University, Health Information Technology, Health Technology, Healthy Living Apps, Information and Support for Carers, Information and Support for Patients and Carers, Information Pathways for Assistive Technology in Dementia Care, Information Technology, Investment in Information Technology, iOS apps, Knowledge Hub (Philippa Lynch), Life Stories, Life Story, Life Story Work, Life Story Work in Dementia Care, Maintaining Independence, Meaningful Activity, Meaningful Activity and Occupation, Meaningful Occupation, Meaningful Relationships, Music Therapy, Music Therapy for BPSD, Musical Interventions, Musical Therapies, National Endowment for Science Technology and the Arts (NESTA), NESTA: National Endowment for Science Technology and the Arts, New Technology, Participation in Research, Participatory and Citizen Involvement, Participatory Arts, Patient Activation, Patient Choice, Patient Control, Patient Empowerment, Patient Experience, Patient Involvement, Patient Involvement in Research, Playlist for Life (Nesta backed by Glasgow Caledonian University), Public Participation in Research, Quality Statement 1: Participation in Meaningful Activity, Regaining Independence, Reminiscence, Reminiscence and Sensory Stimulation, Reminiscence Arts, Reminiscence Services, Reminiscence Therapy, Significant Dates (Reminiscence), Significant Events (Reminiscence), Significant Others (Reminiscence), Significant Persons (Reminiscence), Significant Places (Reminiscence), Smartphone and Tablet Apps, Smartphone apps, Smartphone Mobile Applications to Monitor Symptoms of Mental Health Conditions, Smartphones, Technology and Social Care, Technology and the Arts, Tele-Interventions, Telehealth and Self Care, Telemedicine, Telemonitoring, Transformational Technologies, Transformative Technology, Use and Awareness of Assistive Technology in Community Care, Use and Awareness of Assistive Technology in Dementia Care, Wearable Devices, Wearable Devices for People With Dementia, Wearable Sensors, Wearable Technologies Innovation, Wearable Technology, Wearables (Technology)
|
Leave a comment
Deep and Frequent Phenotyping Study: Dementia Early Detection and Biomarkers Research Programme (MRC / NIHR)
Summary The Deep and Frequent Phenotyping Study will explore improvements in biomarker research and the development of tests to detect Alzheimer’s Disease early on. This research programme will be funded by the National Institute of Health Research (NIHR) and the … Continue reading →
Posted in Alzheimer's Society, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, NIHR, Quick Insights, UK, Universal Interest
|
Tagged Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Aridhia, AstraZeneca / MedImmune, Berry Consultants, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Cognition, Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Dr Rob Buckle: Director of Science Programmes at MRC, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Exprodo, Gait and Cognition, Gait Changes, Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, IXICO, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Ophthalmological Assessments, Optos, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Chris Whitty: Chief Scientific Adviser at Department of Health, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Sage Bionetworks, Surrogate Biomarkers of Neurodegeneration, Translational Research, TrialSpark, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology), West London Mental Health Trust / Imperial College London
|
1 Comment
